619 related articles for article (PubMed ID: 19190827)
1. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study.
Toulon P; Ozier Y; Ankri A; Fléron MH; Leroux G; Samama CM
Thromb Haemost; 2009 Feb; 101(2):394-401. PubMed ID: 19190827
[TBL] [Abstract][Full Text] [Related]
2. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?
Urwyler N; Staub LP; Beran D; Deplazes M; Lord SJ; Alberio L; Theiler L; Greif R
Thromb Haemost; 2009 Oct; 102(4):779-86. PubMed ID: 19806266
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care versus central laboratory testing: an economic analysis in an academic medical center.
Tsai WW; Nash DB; Seamonds B; Weir GJ
Clin Ther; 1994; 16(5):898-910; discussion 854. PubMed ID: 7859247
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a point-of-care coagulation analyzer on patients undergoing cardiopulmonary bypass surgery.
Chavez JJ; Weatherall JS; Strevels SM; Liu F; Snider CC; Carroll RC
J Clin Anesth; 2004 Feb; 16(1):7-10. PubMed ID: 14984853
[TBL] [Abstract][Full Text] [Related]
5. Results of the performance verification of the CoaguChek XS system.
Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM
Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761
[TBL] [Abstract][Full Text] [Related]
6. Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients.
Ferring M; Reber G; de Moerloose P; Merlani P; Diby M; Ricou B
Can J Anaesth; 2001 Dec; 48(11):1155-60. PubMed ID: 11744594
[TBL] [Abstract][Full Text] [Related]
7. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.
Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A
J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246
[TBL] [Abstract][Full Text] [Related]
8. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
[TBL] [Abstract][Full Text] [Related]
9. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring.
Ryan F; O'Shea S; Byrne S
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care testing of neonatal coagulation.
Tan K; Booth D; Newell SJ; Dear PR; Hughes C; Richards M
Clin Lab Haematol; 2006 Apr; 28(2):117-21. PubMed ID: 16630216
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin measurement using a patient self-testing system. Oral Anticoagulation Monitoring Study Group.
Oral Anticoagulation Monitoring Study Group
Am J Clin Pathol; 2001 Feb; 115(2):280-7. PubMed ID: 11211618
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
[TBL] [Abstract][Full Text] [Related]
13. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
Abdel-Wahab OI; Healy B; Dzik WH
Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery.
Choi TS; Greilich PE; Shi C; Wilson JS; Keller A; Kroll MH
Am J Clin Pathol; 2002 Jan; 117(1):74-8. PubMed ID: 11789734
[TBL] [Abstract][Full Text] [Related]
15. Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery.
Meesters MI; Vonk AB; van de Weerdt EK; Kamminga S; Boer C
Thromb Res; 2014 Jun; 133(6):1141-4. PubMed ID: 24703296
[TBL] [Abstract][Full Text] [Related]
16. [Manageability and potential for haemostasis monitoring by near-patient modified thromboelastometer (Rotem) in intensive care unit].
Savry C; Quinio P; Lefèvre F; Schmitt F
Ann Fr Anesth Reanim; 2005 Jun; 24(6):607-16. PubMed ID: 15922540
[TBL] [Abstract][Full Text] [Related]
17. Effect of drawing a discard tube on PT and APTT results in healthy adults.
Bamberg R; Cottle JN; Williams JC
Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
[TBL] [Abstract][Full Text] [Related]
18. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
Ganter MT; Hofer CK
Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
